Beyond Appetite: Therapeutic Ketosis as a Novel Metabolic Axis for High-Quality Weight Loss
8:30 am - Thursday 16th July 2026
- Introducing therapeutic ketosis as a novel metabolic pathway beyond GLP-1 therapies to enhance energy expenditure, improve metabolic flexibility, and complement appetite-based mechanisms for obesity treatment
- Presenting preclinical evidence that oral ketone therapy delivers high-quality weight loss by preferentially reducing fat mass while preserving lean muscle and improving key markers of metabolic health, including liver inflammation and fibrosis
- Exploring the role of ketone therapeutics as combination and maintenance therapies to improve long-term durability, minimize post-GLP-1 weight regain, and redefine obesity treatment from weight reduction to sustainable metabolic disease modification
